Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-27 @ 2:24 PM
Study NCT ID:
NCT04757857
Status:
TERMINATED
Last Update Posted:
2023-01-25
First Post:
2021-02-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
COVID-19 Antithrombotic Rivaroxaban Evaluation
Sponsor:
Hospital Alemão Oswaldo Cruz
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
36066320.5.1001.0070
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None